Trial intelligence / Profile preview

Dacomitinib vs erlotinib in advanced non-small cell lung cancer

CTR20132919Phase 3Completed

Sponsor

Pfizer

Start

Apr 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1